title: Management of antiangiogenic therapy-induced hypertension.
authors.affiliation: Division of Nephrology, Boston Children's Hospital, Boston, MA, USA.
authors.forename: Nilka
authors.initials: N
authors.lastname: de Jesus-Gonzalez
authors.forename: Emily
authors.initials: E
authors.lastname: Robinson
authors.forename: Javid
authors.initials: J
authors.lastname: Moslehi
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Humphreys
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery; D017706:Lisinopril / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D020533:Angiogenesis Inhibitors; D000959:Antihypertensive Agents; D007211:Indoles; D011758:Pyrroles; D017706:Lisinopril; D000077210:Sunitinib